Logo image of ALEUP.PA

EUROPLASMA (ALEUP.PA) Stock Fundamental Analysis

EPA:ALEUP - Euronext Paris - Matif - FR001400PDG8 - Common Stock - Currency: EUR

0.0087  0 (-1.14%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to ALEUP. ALEUP was compared to 43 industry peers in the Commercial Services & Supplies industry. ALEUP may be in some trouble as it scores bad on both profitability and health. ALEUP has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ALEUP has reported negative net income.
In the past year ALEUP has reported a negative cash flow from operations.
ALEUP had negative earnings in each of the past 5 years.
In the past 5 years ALEUP always reported negative operating cash flow.
ALEUP.PA Yearly Net Income VS EBIT VS OCF VS FCFALEUP.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M -50M

1.2 Ratios

With a Return On Assets value of -14.70%, ALEUP is not doing good in the industry: 86.05% of the companies in the same industry are doing better.
The Return On Equity of ALEUP (-154.05%) is worse than 88.37% of its industry peers.
Industry RankSector Rank
ROA -14.7%
ROE -154.05%
ROIC N/A
ROA(3y)-31.01%
ROA(5y)-37.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALEUP.PA Yearly ROA, ROE, ROICALEUP.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K 2K

1.3 Margins

Looking at the Gross Margin, with a value of 10.61%, ALEUP is doing worse than 81.40% of the companies in the same industry.
ALEUP's Gross Margin has been stable in the last couple of years.
ALEUP does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y0.18%
ALEUP.PA Yearly Profit, Operating, Gross MarginsALEUP.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -100 -200 -300 -400

More info and screens

0

2. Health

2.1 Basic Checks

ALEUP does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALEUP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALEUP has more shares outstanding
ALEUP has a worse debt/assets ratio than last year.
ALEUP.PA Yearly Shares OutstandingALEUP.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20K 40K 60K
ALEUP.PA Yearly Total Debt VS Total AssetsALEUP.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M 50M

2.2 Solvency

ALEUP has an Altman-Z score of -2.21. This is a bad value and indicates that ALEUP is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.21, ALEUP is not doing good in the industry: 86.05% of the companies in the same industry are doing better.
A Debt/Equity ratio of 1.03 is on the high side and indicates that ALEUP has dependencies on debt financing.
ALEUP has a Debt to Equity ratio of 1.03. This is comparable to the rest of the industry: ALEUP outperforms 41.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Altman-Z -2.21
ROIC/WACCN/A
WACC5.67%
ALEUP.PA Yearly LT Debt VS Equity VS FCFALEUP.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M 20M -20M -30M

2.3 Liquidity

ALEUP has a Current Ratio of 0.74. This is a bad value and indicates that ALEUP is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.74, ALEUP is not doing good in the industry: 83.72% of the companies in the same industry are doing better.
ALEUP has a Quick Ratio of 0.74. This is a bad value and indicates that ALEUP is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ALEUP (0.35) is worse than 90.70% of its industry peers.
Industry RankSector Rank
Current Ratio 0.74
Quick Ratio 0.35
ALEUP.PA Yearly Current Assets VS Current LiabilitesALEUP.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M

More info and screens

2

3. Growth

3.1 Past

ALEUP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 97.42%, which is quite impressive.
Looking at the last year, ALEUP shows a very strong growth in Revenue. The Revenue has grown by 64.73%.
ALEUP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.40% yearly.
EPS 1Y (TTM)97.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
Revenue 1Y (TTM)64.73%
Revenue growth 3Y59.52%
Revenue growth 5Y6.4%
Sales Q2Q%117.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALEUP.PA Yearly Revenue VS EstimatesALEUP.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M
ALEUP.PA Yearly EPS VS EstimatesALEUP.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2017 -5B -10B -15B -20B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALEUP. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALEUP.PA Price Earnings VS Forward Price EarningsALEUP.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALEUP.PA Per share dataALEUP.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -100 -200 -300 -400

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALEUP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EUROPLASMA

EPA:ALEUP (6/2/2025, 7:00:00 PM)

0.0087

0 (-1.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)05-19 2025-05-19
Earnings (Next)10-29 2025-10-29
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.60M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.4
P/FCF N/A
P/OCF N/A
P/B 1.46
P/tB 1.5
EV/EBITDA N/A
EPS(TTM)-462.4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.02
BVpS0.01
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.7%
ROE -154.05%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.61%
FCFM N/A
ROA(3y)-31.01%
ROA(5y)-37.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y0.18%
F-Score5
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 1.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.16%
Cap/Sales 6.19%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.74
Quick Ratio 0.35
Altman-Z -2.21
F-Score5
WACC5.67%
ROIC/WACCN/A
Cap/Depr(3y)90.95%
Cap/Depr(5y)106.41%
Cap/Sales(3y)28.87%
Cap/Sales(5y)45.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)97.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)64.73%
Revenue growth 3Y59.52%
Revenue growth 5Y6.4%
Sales Q2Q%117.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-29.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.4%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y60.59%
OCF growth 3YN/A
OCF growth 5YN/A